Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Population pharmacokinetics and exposure-response relationship of amatuximab, an anti-mesothelin monoclonal antibody, in patients with malignant pleural mesothelioma and its application in dose selection.

Gupta A, Hussein Z, Hassan R, Wustner J, Maltzman JD, Wallin BA.

Cancer Chemother Pharmacol. 2016 Apr;77(4):733-43. doi: 10.1007/s00280-016-2984-z. Epub 2016 Feb 22.

PMID:
26898299
2.

Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma.

Hassan R, Kindler HL, Jahan T, Bazhenova L, Reck M, Thomas A, Pastan I, Parno J, O'Shannessy DJ, Fatato P, Maltzman JD, Wallin BA.

Clin Cancer Res. 2014 Dec 1;20(23):5927-36. doi: 10.1158/1078-0432.CCR-14-0804. Epub 2014 Sep 17.

3.

Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery.

Delaney CP, Weese JL, Hyman NH, Bauer J, Techner L, Gabriel K, Du W, Schmidt WK, Wallin BA; Alvimopan Postoperative Ileus Study Group.

Dis Colon Rectum. 2005 Jun;48(6):1114-25; discussion 1125-6; author reply 1127-9.

PMID:
15906123
4.

Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus.

Wolff BG, Michelassi F, Gerkin TM, Techner L, Gabriel K, Du W, Wallin BA; Alvimopan Postoperative Ileus Study Group.

Ann Surg. 2004 Oct;240(4):728-34; discussion 734-5.

5.

Lack of a clinically significant pharmacokinetic interaction between fenofibrate and pravastatin in healthy volunteers.

Pan WJ, Gustavson LE, Achari R, Rieser MJ, Ye X, Gutterman C, Wallin BA.

J Clin Pharmacol. 2000 Mar;40(3):316-23.

PMID:
10709162
6.

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.

Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB.

Am J Psychiatry. 1997 Jun;154(6):782-91.

PMID:
9167505
7.

Illness characteristics of patients in clinical drug studies of mania.

Bowden CL, Calabrese JR, Wallin BA, Swann AC, McElroy SL, Risch SC, Hirschfeld MA.

Psychopharmacol Bull. 1995;31(1):103-9. Review.

PMID:
7675973
8.

The clinical and health status of patients with recent-onset rheumatoid arthritis.

Meenan RF, Kazis LE, Anthony JM, Wallin BA.

Arthritis Rheum. 1991 Jun;34(6):761-5.

PMID:
2053922
9.

Reduction of indomethacin induced gastroduodenal mucosal injury and gastrointestinal symptoms with cimetidine in normal subjects.

Frank WO, Wallin BA, Berkowitz JM, Kimmey MB, Palmer RH, Rockhold F, Young MD.

J Rheumatol. 1989 Sep;16(9):1249-52.

PMID:
2810283
10.

Misoprostol versus cimetidine in tolmetin-induced mucosal injury.

Wallin BA, Frank WO, Young MD.

Gastroenterology. 1989 May;96(5 Pt 1):1374-6. No abstract available.

PMID:
2495235
11.

A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.

Carette S, Calin A, McCafferty JP, Wallin BA.

Arthritis Rheum. 1989 Feb;32(2):158-65.

PMID:
2645874
12.

Incidence and management of diarrhea during longterm auranofin therapy.

Wallin BA, McCafferty JP, Fox MJ, Cooper DR, Goldschmidt MS.

J Rheumatol. 1988 Dec;15(12):1755-8.

PMID:
3265956
13.

Cimetidine and effect of warfarin.

Wallin BA, Jacknowitz A, Raich PC.

Ann Intern Med. 1979 Jun;90(6):993. No abstract available.

PMID:
443703

Supplemental Content

Loading ...
Support Center